CD4 and neoplasm: Additionally, in the GL261 model, the CD4+ T cell compartment has been shown to contribute to anti-tumor immunity through promotion of Th1 and Th17 differentiation, but also serve a suppressive role through the activity of regulatory T cells[14, 41, 42].